Table 2.

Seaweeds polysaccharides and their roles in foods and cosmeceuticals.

Component	Species	Models	Doses	MW	Activity	Results	References
Carrageenan	Padina tetrastromatic	Paw edema in rats	20 mg kg−1	25 kDa	Anti-inflammation	COX-2 and iNOS inhibitions	[49]
Fucoidan	Fucus vesiculosus	Human malignant melanoma cells	100–400 µg mL−1	60 kDa	Anticancer activity	Inhibit cell proliferation	[50]
		B16 murine melanoma cells	550 µg mL−1	-	Anti-melanogenic	Inhibit tyrosinase and melanin	[51]
Ulvans	Ulva sp.	Human dermal fibroblast	100 and 500 µg mL−1	4–57 kDa	Anti-aging	Increase hyaluronan production	[52]
Laminaran	Laminaria japonica	In vitro	15 mg mL−1	250 kDa	antioxidant activity	ROS scavenging potential	[53]
Fucoidan	Chnoospora minima	RAW macrophages	27.82 µg mL−1	60 kDa	Anti-inflammation	Inhibition of LPS-induced NO production, iNOS, COX-2, and PGE2 levels	[54]
Fucoidan	Sargassum hemiphyllum	RAW 264.7 macrophage cells	dose-dependent manner	-	Anti-inflammation	Inhibit LPS-induced inflammatory response	[55]
Fucoidan	Sargassum hemiphyllum	B16 melanoma cells	dose-dependent manner	-	Anticancer	Activation of caspase-3	[56]